
Home > Newsroom > 2006 > Notice of Execution of Acquisition of the Company's Own Shares
Main contents starts here
September 25, 2006
Osaka, Japan, September 25, 2006 --- Takeda Pharmaceutical Company Limited ("Takeda") announced today that it completed acquisition of its own shares in the market, which was resolved by its Board of Directors on September 7, 2006.
| 1. Type of shares acquired | : | Shares of common stock |
|---|---|---|
| 2. Period of acquisition | : | From September 8, 2006 to September 22, 2006 |
| 3. Total number of shared acquired | : | 4,482,700 shares |
| 4. Total value of acquisition | : | Yen 33,581,053,000 |
| 5. Method of acquisition | : | Purchased on the Tokyo Stock Exchange |
| 1. Type of shares to be acquired | : | Shares of common stock |
|---|---|---|
| 2. Number of shares to be acquired | : | Up to 8,400 thousand shares |
| (equivalent to 0.94% of a total of issued shares) | ||
| 3. Total value of shares to be acquired | : | Up to 57 billion Yen |
| 4. Schedule of acquisition | : | From September 8, 2006 to September 22, 2006 |
# # #